Jamp Venlafaxine Xr 37.5 Mg Capsules; Mislabelling
JAMP Venlafaxine XR 37.5 mg capsules are being recalled in Canada due to mislabeling on the packaging. This is a Class I recall, which is the most serious classification. The affected product was distributed across Canada.
- Product
- JAMP Venlafaxine XR 37.5 mg capsules
- Reason
- Labelling
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-06-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/8e6f8625-d618-42c6-8e25-d006bb174ea9